Appointed
Travis Joyner
Chairman of the Board
LOCL ·
Local Bounti Corporation/DE
the Board has appointed Travis Joyner as Chairman of the Board
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 651–700 of 75328
Departed
Craig Hurlbert
Executive Chairman
LOCL ·
Local Bounti Corporation/DE
Craig Hurlbert announced his intention to resign as Executive Chairman and as a member of the Board of Directors (the “Board”) of Local Bounti Corporation (the “Company”), effective as of June 18, 2026.
Departed
M. Dean Brown
Chief Operations and Technology Officer
BRBS ·
BLUE RIDGE BANKSHARES, INC.
effective June 30, 2026, the position of Chief Operations and Technology Officer of Blue Ridge Bankshares, Inc. and its wholly owned subsidiary Blue Ridge Bank, National Association (the “Bank”) held by M. Dean Brown will be eliminated as part of the Company’s cost reduction efforts, and his employment will be terminated without cause effective June 30, 2026.
Departed
Michael Cuffe
Executive Vice President and Chief Clinical Officer
HCA ·
HCA Healthcare, Inc.
On June 15, 2026, Dr. Michael Cuffe and HCA Healthcare, Inc. (the “Company”) agreed that Dr. Cuffe will step down as Executive Vice President and Chief Clinical Officer effective August 31, 2026, and thereafter continue in a transitional role with the Company until February 2027.
Appointed
Matthew Domeyer
Chief Financial Officer
AEYE ·
AUDIOEYE INC
approved the election of Matthew Domeyer to the position of Chief Financial Officer of the Company, to be effective on July 20, 2026
Appointed
(interim)
Richard Kaiser
interim Chief Executive Officer
BFNH ·
BIOFORCE NANOSCIENCES HOLDINGS, INC.
On June 17, 2026, the Company’s Board of Directors appointed Richard Kaiser as the Company’s interim Chief Executive Officer.
Departed
John LaViolette
Co-Chief Executive Officer
BFNH ·
BIOFORCE NANOSCIENCES HOLDINGS, INC.
On June 17, 2026, the Company’s Board of Directors received resignation letters from Mr. Steven Gagnon and Mr. John LaViolette as BioForce Nanosciences Holdings, Inc.’s Co-Chief Executive Officers (CEOs), and from Sasha Shapiro the Company’s Vice-President.
Appointed
Scott Mager
Director
BFNH ·
BIOFORCE NANOSCIENCES HOLDINGS, INC.
Effective June 15, 2026, the Board of Directors appointed Scott Mager as Directors of the Company.
Departed
Steven Gagnon
Co-Chief Executive Officer
BFNH ·
BIOFORCE NANOSCIENCES HOLDINGS, INC.
On June 17, 2026, the Company’s Board of Directors received resignation letters from Mr. Steven Gagnon and Mr. John LaViolette as BioForce Nanosciences Holdings, Inc.’s Co-Chief Executive Officers (CEOs), and from Sasha Shapiro the Company’s Vice-President.
Departed
Sasha Shapiro
Vice-President
BFNH ·
BIOFORCE NANOSCIENCES HOLDINGS, INC.
On June 17, 2026, the Company’s Board of Directors received resignation letters from Mr. Steven Gagnon and Mr. John LaViolette as BioForce Nanosciences Holdings, Inc.’s Co-Chief Executive Officers (CEOs), and from Sasha Shapiro the Company’s Vice-President.
Appointed
Brian C. White
Class III Director
ALGM ·
ALLEGRO MICROSYSTEMS, INC.
elected Brian C. White to the Board as a Class III Director
Departed
Cory Onell
Executive Vice President and Chief Omnichannel Sales and Asia Emerging Markets Officer
KHC ·
Kraft Heinz Co
On June 18, 2026, The Kraft Heinz Company (the “Company”) announced that Cory Onell, Executive Vice President and Chief Omnichannel Sales and Asia Emerging Markets Officer, will step down from his role effective June 30, 2026 to pursue other opportunities.
Appointed
(interim)
Cecile Guegan
Interim Chief Financial Officer
PFE ·
PFIZER INC
the Company announced that Cecile Guegan, the Company’s Senior Vice President, Finance, Global Biopharmaceutical Business, will serve as Interim Chief Financial Officer, effective August 16, 2026
Departed
(interim)
Dave Denton
Chief Financial Officer
PFE ·
PFIZER INC
Dave Denton notified Pfizer Inc. (the “Company”) that he will step down from his current position as Chief Financial Officer effective August 15, 2026
Appointed
Michael McCormick
Chief Executive Officer and President
NUWE ·
Nuwellis, Inc.
Effective as of June 30, 2026, the Board appointed Michael McCormick as the Company’s Chief Executive Officer and President and member of the Company’s board of directors.
Departed
John L. Erb
President and Chief Executive Officer
NUWE ·
Nuwellis, Inc.
On June 16, 2026, Nuwellis, Inc. (the “Company” ) announced that John L. Erb resigned from the Company, effective June 30, 2026 (“ Resignation Date ”).
Appointed
Michael McCormick
Member of the Board of Directors
NUWE ·
Nuwellis, Inc.
Effective as of June 30, 2026, the Board appointed Michael McCormick as the Company’s Chief Executive Officer and President and member of the Company’s board of directors.
Departed
Richard Morrissy
Director
LIFD ·
LFTD PARTNERS INC.
On June 14, 2026, Richard (“Rich”) Morrissy notified LFTD Partners Inc. (the “Company”) of his resignation from the Company’s Board of Directors, effective immediately.
Departed
Edward McDonough
Director
PKTX ·
ProtoKinetix, Inc.
On March 31, 2026, Mr. Edward McDonough, after serving many years as a trusted advisor to ProtoKinetix, Incorporated (the “Company”) under the leadership of Clarence E. Smith, notified the Board of Directors of the Company (the “Board”) of his resignation from the Board effective immediately.
Appointed
Keith Brunt
Director
PKTX ·
ProtoKinetix, Inc.
On June 17, 2026, Keith Brunt, a Translational Scientist and Associate Professor of Pharmacology, in the Faculty of Medicine at Dalhousie Medicine in New Brunswick, was appointed as a director and as the president of the Company, to hold such office until his successors are duly elected and qualified.
Appointed
Keith Brunt
President
PKTX ·
ProtoKinetix, Inc.
On June 17, 2026, Keith Brunt, a Translational Scientist and Associate Professor of Pharmacology, in the Faculty of Medicine at Dalhousie Medicine in New Brunswick, was appointed as a director and as the president of the Company, to hold such office until his successors are duly elected and qualified.
Appointed
Michael Jones
Director
PKTX ·
ProtoKinetix, Inc.
On June 17, 2026, Michael Jones, of Corbin, Kentucky, and Jason Lamp, of Roswell, Georgia were appointed as directors of the Company to serve as members of the Board, and to hold such office until their successors are duly elected and qualified.
Appointed
Jason Lamp
Director
PKTX ·
ProtoKinetix, Inc.
On June 17, 2026, Michael Jones, of Corbin, Kentucky, and Jason Lamp, of Roswell, Georgia were appointed as directors of the Company to serve as members of the Board, and to hold such office until their successors are duly elected and qualified.
Departed
David Grizzle
Chief Executive Officer
RJET ·
REPUBLIC AIRWAYS HOLDINGS INC.
On June 15, 2026, concurrent with Mr. Koscal's succession to the Chief Executive Officer role, David Grizzle, the Company's former Chief Executive Officer for a transitional period that commenced on July 1, 2025, resumed his position as non-executive Chairman of the Board
Role change
Paul K. Kinstedt
Executive Vice President
RJET ·
REPUBLIC AIRWAYS HOLDINGS INC.
In connection with the promotion of each of Mr. Joseph P. Allman, the Company's Chief Financial Officer and Paul K. Kinstedt, the Company's Chief Operating Officer, to the role of Executive Vice President, effective as of June 15, 2026
Appointed
David Grizzle
non-executive Chairman of the Board
RJET ·
REPUBLIC AIRWAYS HOLDINGS INC.
David Grizzle, the Company's former Chief Executive Officer for a transitional period that commenced on July 1, 2025, resumed his position as non-executive Chairman of the Board and rejoined the Corporate Governance Committee.
Role change
Joseph P. Allman
Executive Vice President
RJET ·
REPUBLIC AIRWAYS HOLDINGS INC.
In connection with the promotion of each of Mr. Joseph P. Allman, the Company's Chief Financial Officer and Paul K. Kinstedt, the Company's Chief Operating Officer, to the role of Executive Vice President, effective as of June 15, 2026
Appointed
Matthew J. Koscal
President and Chief Executive Officer
RJET ·
REPUBLIC AIRWAYS HOLDINGS INC.
increased the size of the Board to seven and appointed Matthew J. Koscal as a director, effective June 15, 2026, to serve until the Company's 2027 Annual Meeting of Stockholders, and until the election and qualification of his successor, or earlier death, resignation, retirement, disqualification or removal.
Departed
Joanne Curley
Director
VTGN ·
Vistagen Therapeutics, Inc.
On June 16, 2026, Ms. Margaret FitzPatrick, and on June 17, 2026, Dr. Joanne Curley, each a member of the Board of Directors of Vistagen Therapeutics, Inc. (the “ Company ”), notified the Company of her decision not to stand for re-election at the Company’s 2026 Annual Meeting of Stockholders.
Departed
Margaret FitzPatrick
Director
VTGN ·
Vistagen Therapeutics, Inc.
On June 16, 2026, Ms. Margaret FitzPatrick, and on June 17, 2026, Dr. Joanne Curley, each a member of the Board of Directors of Vistagen Therapeutics, Inc. (the “ Company ”), notified the Company of her decision not to stand for re-election at the Company’s 2026 Annual Meeting of Stockholders.
Departed
Devin Cole
Chief Operating Officer
TSN ·
TYSON FOODS, INC.
Devin Cole would step down from his role as Chief Operating Officer effective that same day.
Appointed
Wes Morris
Chief Operating Officer
TSN ·
TYSON FOODS, INC.
Wes Morris had been appointed Chief Operating Officer, effective June 15, 2026
Role change
David Grizzle
non-executive Chairman of the Board of Directors
RJET ·
REPUBLIC AIRWAYS HOLDINGS INC.
Mr. Grizzle resumed the role of non-executive Chairman of the Board of Directors
Appointed
Matthew J. Koscal
President and Chief Executive Officer
RJET ·
REPUBLIC AIRWAYS HOLDINGS INC.
promoted Matthew J. Koscal to the role of President and Chief Executive Officer (principal executive officer), effective as of June 15, 2026
Appointed
Jill Livesay
non-employee director
PUBLIX SUPER MARKETS INC
elected Jill Livesay as a non-employee director of the Board (Election), with such increase and Election effective as of July 1, 2026
Appointed
John E. Gallagher
Executive Vice President, Chief Financial Officer
CNMD ·
CONMED Corp
On June 17, 2026, CONMED Corporation (the “Company”) announced that John E. Gallagher has been appointed to serve as the Company’s Executive Vice President, Chief Financial Officer beginning July 15, 2026 (the “Effective Date”).
Appointed
Cory T. Newsom
Chief Executive Officer
SPFI ·
SOUTH PLAINS FINANCIAL, INC.
the board of directors of the Company appointed Mr. Cory T. Newsom to serve as the Chief Executive Officer of the Company, effective upon Mr. Griffith’s retirement on December 31, 2026.
Role change
Curtis C. Griffith
Chief Executive Officer
SPFI ·
SOUTH PLAINS FINANCIAL, INC.
Mr. Griffith’s retirement as Chief Executive Officer will be effective as of December 31, 2026.
Departed
Theodore Ralston
Director
CITR ·
CitroTech Inc.
On June 12, 2026, Theodore Ralston and Jeffery Pomerantz notified CitroTech Inc., a Wyoming corporation (the “Company”), of their resignations from the Company’s board of directors (the “Board”), effective immediately.
Appointed
Michael Feigin
Director
CITR ·
CitroTech Inc.
On June17, 2026, upon the recommendation of the Board’s nominating and corporate governance committee (the “Nominating Committee”), the Board appointed Michael Feigin to fill one of the two vacancies, effective immediately.
Departed
Jeffery Pomerantz
Director
CITR ·
CitroTech Inc.
Neither Mr. Ralston’s nor Mr. Pomerantz’s resignations arose from or related to a dispute with management or the Board.
Departed
Daniel L. Poland
Executive Vice President, Chief Enterprise Transformation Officer
CPB ·
CAMPBELL'S Co
On June 17, 2026, The Campbell’s Company (the “Company”) announced that Daniel L. Poland, Executive Vice President, Chief Enterprise Transformation Officer, will step down from his current role effective August 3, 2026.
Appointed
Jayant Chauhan
Executive Vice President, Chief Financial Officer and Principal Financial Officer
INOD ·
INNODATA INC
On June 17, 2026, the Company also announced the appointment of its new Executive Vice President, Chief Financial Officer and Principal Financial Officer, Mr. Jayant Chauhan, effective as of July 6, 2026.
Role change
Marissa Espineli
Chief Accounting Officer
INOD ·
INNODATA INC
Effective as of Mr. Chauhan’s appointment date Ms. Marissa Espineli, who is currently serving as the Company’s Interim Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer, will transition to the role of Chief Accounting Officer and will continue to serve as the Company’s Principal Accounting Officer.
Appointed
Stacey Moser
Chief Customer Officer
VRRM ·
VERRA MOBILITY Corp
On June 13, 2026, the Compensation Committee (the “Compensation Committee”) of the Board of Directors (the “Board”) of Verra Mobility Corporation (the “Company”) approved the grant of an equity award to Stacey Moser, who has been named the Company’s Chief Customer Officer, where she will oversee sales, account management and marketing for the Company’s Commercial Services and Government Solutions segments.
Appointed
Adrian Rodriguez
Chief Operating Officer
AMTB ·
Amerant Bancorp Inc.
On May 26, 2026 (the “Effective Date”), Amerant Bancorp Inc. (the “Company”) and its main subsidiary, Amerant Bank, N.A. (the “Bank”), appointed Adrian Rodriguez as Executive Vice President and Chief Operating Officer.
Departed
John E. Gallagher III
Chief Financial Officer
CERT ·
Certara, Inc.
On June 11, 2026, John E. Gallagher III, Senior Vice President and Chief Financial Officer of Certara, Inc. (the “Company”), tendered his notice of resignation to the Company to pursue another opportunity.
Appointed
(interim)
Faiz Mohammed
Interim Chief Financial Officer
CERT ·
Certara, Inc.
On June 17, 2026, the Company appointed Faiz Mohammed as its Interim Chief Financial Officer and as both principal financial officer and principal accounting officer of the Company for purposes of the Securities Exchange Act of 1934, as amended, effective as of the Effective Date and until a successor may be appointed.
Appointed
Nina Barton
Executive Vice President and Chief Growth & Strategy Officer
CLX ·
CLOROX CO /DE/
Nina Barton, formerly Executive Vice President and Group President – Care & Connection, was appointed Executive Vice President and Chief Growth & Strategy Officer, effective June 17, 2026.
Appointed
Tyler Krutzig
Senior Vice President and Chief Accounting Officer
NVT ·
nVent Electric plc
On June 12, 2026, the Board of Directors of the Company appointed Tyler Krutzig as Senior Vice President and Chief Accounting Officer of the Company effective September 1, 2026.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.